Cargando…
Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR(-/-) Mice on Western Type Diet
OBJECTIVE: To investigate therapeutic effects of annexin A1 (anxA1) on atherogenesis in LDLR(-/-) mice. METHODS: Human recombinant annexin A1 (hr-anxA1) was produced by a prokaryotic expression system, purified and analysed on phosphatidylserine (PS) binding and formyl peptide receptor (FPR) activat...
Autores principales: | Kusters, Dennis H. M., Chatrou, Martijn L., Willems, Brecht A. G., De Saint-Hubert, Marijke, Bauwens, Matthias, van der Vorst, Emiel, Bena, Stefania, Biessen, Erik A. L., Perretti, Mauro, Schurgers, Leon J., Reutelingsperger, Chris P. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475013/ https://www.ncbi.nlm.nih.gov/pubmed/26090792 http://dx.doi.org/10.1371/journal.pone.0130484 |
Ejemplares similares
-
AnxA5 reduces plaque inflammation of advanced atherosclerotic lesions in apoE(−/−) mice
por: Burgmaier, Mathias, et al.
Publicado: (2014) -
Molecular Imaging of Cell Death in Tumors. Increasing Annexin A5 Size Reduces Contribution of Phosphatidylserine-Targeting Function to Tumor Uptake
por: Ungethüm, Lisette, et al.
Publicado: (2014) -
Vitamin K-Antagonists Accelerate Atherosclerotic Calcification and Induce a Vulnerable Plaque Phenotype
por: Schurgers, Leon J., et al.
Publicado: (2012) -
Annexin A5 reduces early plaque formation in ApoE -/- mice
por: Stöhr, Robert, et al.
Publicado: (2017) -
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
por: Locatelli, Irene, et al.
Publicado: (2014)